A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

NCT02493712 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: High dose
DRUG: Low dose
DRUG: Placebo

Sponsor

Holy Stone Healthcare Co., Ltd

Collaborators

[object Object]